Patient-reported outcome changes at the end of life in recurrent platinum-resistant ovarian cancer: An NRG oncology/GOG study.

MLA

Wenzel, Lari, et al. “Patient-Reported Outcome Changes at the End of Life in Recurrent Platinum-Resistant Ovarian Cancer: An NRG Oncology/GOG Study.” Gynecologic Oncology, vol. 163, no. 2, Nov. 2021, pp. 392–97. EBSCOhost, https://doi.org/10.1016/j.ygyno.2021.08.028.

APA

Wenzel, L., Huang, H. Q., Cella, D., McKinney, C. O., Zevon, M. A., LaChance, J. A., Walker, J. L., Salani, R., Modesitt, S. C., Morris, R. T., Bradley, W. H., Boente, M. P., & von Gruenigen, V. E. (2021). Patient-reported outcome changes at the end of life in recurrent platinum-resistant ovarian cancer: An NRG oncology/GOG study. Gynecologic Oncology, 163(2), 392–397. https://doi.org/10.1016/j.ygyno.2021.08.028

Chicago

Wenzel, Lari, Helen Q Huang, David Cella, Chelsea O McKinney, Michael A Zevon, Jason A LaChance, Joan L Walker, et al. 2021. “Patient-Reported Outcome Changes at the End of Life in Recurrent Platinum-Resistant Ovarian Cancer: An NRG Oncology/GOG Study.” Gynecologic Oncology 163 (2): 392–97. doi:10.1016/j.ygyno.2021.08.028.